<atl>Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in iBMPR2/i Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)</atl>

Journal:
American Journal of Respiratory and Critical Care Medicine
Published:
DOI:
10.1164/rccm.202409-1698oc
Affiliations:
18
Authors:
19
Go to article
Institutions Authors Share
Merck - Rahway, United States of America (USA)
4.000000
 0.21
Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies, France
1.000000
 0.05
ERN LUNG, France, France
1.000000
 0.05
Michigan Medicine, U-M, United States of America (USA)
1.000000
 0.05
Imperial College London (ICL), United Kingdom (UK)
1.000000
 0.05
The George Washington University (GW), United States of America (USA)
1.000000
 0.05
Hannover Medical School (MHH), Germany
1.000000
 0.05
The German Center for Lung Research (DZL), Germany
1.000000
 0.05
Lahey Hospital and Medical Center, United States of America (USA)
1.000000
 0.05
Hospital das Clínicas da FMUSP, Brazil
1.000000
 0.05
Brigham and Women's Hospital (BWH), United States of America (USA)
1.000000
 0.05
Summit Health, United States of America (USA)
1.000000
 0.05
Irmandade da Santa Casa de Misericórdia de Porto Alegre, Brazil
1.000000
 0.05
AP-HP Pitié-Salpêtrière Hospital, France
1.000000
 0.05
University of Colorado Denver (CU Denver), United States of America (USA)
1.000000
 0.05
Institute of Health Carlos III (ISCIII), Spain
0.333333
 0.02
Hospital Universitario 12 de Octubre, Spain
0.333333
 0.02
Complutense University of Madrid (UCM), Spain
0.333333
 0.02
Interested in Cardiovascular Medicine and Haematology?